GLP1R and diabetes mellitus: Of course, all these recommendations by all these Societies should be intended as clinical practice statements (CPS) and suffer a lack of data supporting them as well as a lack of data on the benefits of continuing GLP-1 RAs during the perioperative period, specifically in patients with diabetes mellitus, cardiovascular risks, and renal disease.